Newly developed cardiovascular risk factors in rheumatoid arthritis patients initiating biologic treatment.

Patients with RA initiating biologics should be screened for cardiometabolic risk factors, especially at an older age. The presence of at least one risk factor may be linked to a worse long-term prognosis.